Eloxx Pharmaceuticals, Inc.
- ELOX
- NASDAQ
- Biotechnology
- Rare Disease Biotech
- Ribosome Modulation
- Premature Stop Codon Therapeutics
$13.03
Today −4.89%Quote Oct 16, 2026, 08:00 PM UTC
−25.75%over the last month
Max drawdown −30.4%From 1-month high −25.8%3 months +11.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$52.6M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$37.67
+189.1% from here
Floor
$12.36
5.1% below price
Where the price sits
12 analysts
Analyst range, low to high
$32.00$43.00
- Price $13.03
- Resistance $14.29–$14.44
- Consensus $37.67
Analysts' average target sits about 189% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ELOXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
10